Literature DB >> 28321925

Effects of 6-month aerobic interval training on skeletal muscle metabolism in middle-aged metabolic syndrome patients.

A Guadalupe-Grau1,2, V E Fernández-Elías3,4, J F Ortega3, F Dela1, J W Helge1, R Mora-Rodriguez3.   

Abstract

Aerobic interval training (AIT) improves the health of metabolic syndrome patients (MetS) more than moderate intensity continuous training. However, AIT has not been shown to reverse all metabolic syndrome risk factors, possibly due to the limited duration of the training programs. Thus, we assessed the effects of 6 months of AIT on cardio-metabolic health and muscle metabolism in middle-aged MetS. Eleven MetS (54.5±0.7 years old) underwent 6 months of 3 days a week supervised AIT program on a cycle ergometer. Cardio-metabolic health was assessed, and muscle biopsies were collected from the vastus lateralis prior and at the end of the program. Body fat mass (-3.8%), waist circumference (-1.8%), systolic (-10.1%), and diastolic (-9.3%) blood pressure were reduced, whereas maximal fat oxidation rate and VO2peak were significantly increased (38.9% and 8.0%, respectively; all P<.05). The remaining components of cardio-metabolic health measured (body weight, blood cholesterol, triglycerides, and glucose) were not changed after the intervention, and likewise, insulin sensitivity (CSi) remained unchanged. Total AMPK (23.4%), GLUT4 (20.5%), endothelial lipase (33.3%) protein expression, and citrate synthase activity (26.0%) increased with training (P<.05). Six months of AIT in MetS raises capacity for fat oxidation during exercise and increases VO2peak in combination with skeletal muscle improvements in mitochondrial enzyme activity. Muscle proteins involved in glucose, fat metabolism, and energy cell balance improved, although this was not reflected by parallel improvements in insulin sensitivity or blood lipid profile.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  aerobic interval training; metabolic syndrome; muscle metabolism

Mesh:

Substances:

Year:  2017        PMID: 28321925     DOI: 10.1111/sms.12881

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  6 in total

Review 1.  Effect of High-Intensity Interval Training on Total, Abdominal and Visceral Fat Mass: A Meta-Analysis.

Authors:  Florie Maillard; Bruno Pereira; Nathalie Boisseau
Journal:  Sports Med       Date:  2018-02       Impact factor: 11.136

Review 2.  Changes in fat oxidation in response to various regimes of high intensity interval training (HIIT).

Authors:  Todd Anthony Astorino; Matthew M Schubert
Journal:  Eur J Appl Physiol       Date:  2017-11-09       Impact factor: 3.078

Review 3.  High-Intensity Interval Training in Cardiac Rehabilitation.

Authors:  Yaoshan Dun; Joshua R Smith; Suixin Liu; Thomas P Olson
Journal:  Clin Geriatr Med       Date:  2019-07-12       Impact factor: 3.076

4.  Effects of High-Intensity Interval vs. Moderate-Intensity Continuous Training on Cardiac Rehabilitation in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Tian Yue; Yan Wang; Hui Liu; Zhaowei Kong; Fengxue Qi
Journal:  Front Cardiovasc Med       Date:  2022-02-23

5.  Effects of Polarized Training on Cardiometabolic Risk Factors in Young Overweight and Obese Women: A Randomized-Controlled Trial.

Authors:  Rafael Zapata-Lamana; Carlos Henríquez-Olguín; Carlos Burgos; Roberto Meneses-Valdés; Igor Cigarroa; Claudio Soto; Valentín E Fernández-Elías; Sonia García-Merino; Rodrigo Ramirez-Campillo; Antonio García-Hermoso; Hugo Cerda-Kohler
Journal:  Front Physiol       Date:  2018-09-18       Impact factor: 4.566

6.  Effects of high vs moderate-intensity intermittent training on functionality, resting heart rate and blood pressure of elderly women.

Authors:  Victor Silveira Coswig; Matheus Barbalho; Rodolfo Raiol; Fabrício Boscolo Del Vecchio; Rodrigo Ramirez-Campillo; Paulo Gentil
Journal:  J Transl Med       Date:  2020-02-17       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.